Gampongan, Lysa .

HRN: 29-41-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2026
AMPICILLIN 1GM (VIAL)
08/06/2026
08/13/2026
IVT
2g
Q6
PROM
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: